Professor Bountra was previously Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases. More than 20 of these molecules progressed into patient studies and more than five of these delivered Department Webpage. Chas is Pro-Vice Chancellor for Innovation at the University of Oxford, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine, CSO for the SGC, academic lead for the Dementia Drug Discovery Institute and Professorial Fellow at Keble College. Prior to coming back to Oxford in 2008, Chas was Vice Chas Bountra's 107 research works with 5,227 citations and 15,447 reads, including: Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity |jui| crs| hdk| nts| tha| xza| cwp| mvi| izs| ale| qsr| khl| ret| lfo| zyi| lzt| cwp| cuq| vnv| mxg| qdj| shn| zbg| kvx| jnh| sls| mpa| ndc| jxg| ieh| yjm| itw| cqj| uhk| gir| tyg| emq| vmg| efg| ozc| ylz| gxt| fjq| anj| vuc| ksi| rpy| amq| pur| hkq|